BackAtricure Overview
Atricure Inc

Atricure Target Price

Where could ATRC trade next? Consensus target price: $56.

Get informed when a big investor buys or sells

+ Follow

Share Price

$51.52

Average Target Price

$56.008.7% upside

6 analysts in the last 4 months

High: $64 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-02NeedhamMike Matson$6424.2% upsideOpen
2026-08-27Piper SandlerMatt O'Brien$6016.5% upsideOpen
2026-08-24BTIGMarie Thibault$556.8% upsideOpen
2026-07-28UBS$503% downsideOpen
2026-07-21Raymond James$520.9% upsideOpen
2026-05-06Canaccord Genuity$556.8% upsideOpen
2026-02-18UBS$556.8% upsideOpen
2026-02-18Canaccord GenuityWilliam Plovanic$532.9% upsideOpen
2026-02-18Oppenheimer$4414.6% downsideOpen
2025-10-30Canaccord GenuityWilliam Plovanic$6424.2% upsideOpen
2025-07-30BTIG$544.8% upsideOpen
2024-07-31Stifel NicolausRick Wise$2649.5% downsideOpen
2024-07-31Piper SandlerMatt O'Brien$4022.4% downsideOpen
2024-07-31BTIGMarie Thibault$532.9% upsideOpen
2024-05-02NeedhamMike Matson$4022.4% downsideOpen
2024-05-02BTIGMarie Thibault$5812.6% upsideOpen
2024-04-23OppenheimerSuraj Kalia$3237.9% downsideOpen
2023-02-06Canaccord Genuity$8157.2% upsideOpen
2022-12-19NeedhamMike Matson$5812.6% upsideOpen
2022-08-03Piper SandlerMatt O'Brien$556.8% upsideOpen
2022-05-04Needham$6730% upsideOpen
2022-05-04Leerink Partners$7545.6% upsideOpen

Atricure (ATRC) FAQ

Atricure (ATRC) currently reports a target price of $56. Use the charts on this page to explore Atricure's target price history and peer comparisons.

Analysts' average 12-month price target for Atricure is $56, about 8.7% upside from the current share price of $51.52. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $56, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atricure, and consider following ATRC for alerts when major investors trade the stock.

Atricure is classified in the Healthcare sector. On target price, it currently shows $56. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATRC with unrelated industries.